Cancer Letters

Cancer Letters

Volume 61, Issue 1, 9 December 1991, Pages 27-33
Cancer Letters

Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon

https://doi.org/10.1016/0304-3835(91)90073-QGet rights and content

Abstract

Foci of aberrant crypts are putative preneoplastic lesions of colon cancer that can be detected in unsectioned colons stained with methylene blue. The ability of this assay to demonstrate chemopreventive activity was evaluated. Male Sprague-Dawley rats received two subcutaneous injections 1 week apart, of 15 mg/kg azoxymethane each. The animals started to receive the test agents in their diet 1 week prior to the first injection of azoxymethane and continuously until killed 5 weeks later. The number of foci of aberrant crypts induced by the treatment of azoxymethane was reduced from 228 foci/animal without any chemopreventive agent to 151 foci/animal by N-acetylcysteine; to 121 foci/animal by dehydroepiandrosterone; to 161 by alpha-difluoromethylornithine; and to 121 by 1,2-oxothiazolidine-4-carboxylate. The other agents (diallyl sulfide, ellagic acid and phenethyl isothiocyanate) did not significantly alter the number of foci/animal induced by azoxymethane. Animals that did not receive azoxymethane had an average of 0.72 foci/animal. Our results suggest that four of the tested agents might reduce azoxymethane-induced colon cancer, which requires confirmation. Further validation of the foci of aberrant crypt in the colon assay to screen chemicals for chemoprevention agents is warranted.

References (43)

  • B.N. Ames

    Dietary carcinogens and anticarcinogens

    Science

    (1983)
  • M. Athar et al.

    Inhibition of benzoyl peroxide-mediated tumor promotion in 7,12-dimethylbenz(a)anthracene-initiated skin of Sencar mice by antioxidants nordihydroguaiaretic acid and diallyl sulfide

    J. Invest. Dermatol.

    (1990)
  • C.W. Boone et al.

    Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review

    Cancer Res.

    (1990)
  • R.L. Chang et al.

    Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo(a)pyrene and (+)-7b,8a-dihydroxy-9a, 10a-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene on mouse skin and in the newborn mouse

    Carcinogenesis

    (1985)
  • S. De Flora et al.

    In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens

    Carcinogenesis

    (1984)
  • R. Garcea et al.

    Reversal by ribo-and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to initiation-selection process of experimental carcinogenesis

    Carcinogenesis

    (1988)
  • R. Darcea et al.

    Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection of experimental carcinogensis

    Toxicol. Pathol.

    (1987)
  • D.B. Gordon et al.

    Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone

    Adv. Enzyme Regul.

    (1987)
  • R. Goyal et al.

    Influence of a cysteine prodrug, L-2-oxothiazolidine-4-carboxylic acid, on the urinary elimination of mercapturic acids of ethylene oxide, dibromoethane and acrylonitrile: a dose-effect study

    Can. J. Physiol. Pharmacol.

    (1989)
  • M.A. Hayes et al.

    Inhibition of hepatocarcinogenic responses to 1,2-dimethylhydrazine by diallyl sulfide, a component of garlic oil

    Carcinogenesis

    (1987)
  • S. Mandal et al.

    Inhibition of N-nitroso-benzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid

    Carcinogenesis

    (1990)
  • Cited by (74)

    • Sex hormones, SHBG and risk of colon and rectal cancer among men and women in the UK Biobank

      2020, Cancer Epidemiology
      Citation Excerpt :

      The sex disparity observed in CRC susceptibility has been attributed to genetic and environmental factors [5–7], both of which can affect sex hormones levels [8–10]. In this regard, experimental studies that have evaluated colonic tumorigenesis in mouse models and human cancer cell lines have mainly shown a protective effect of estrogen, and both pro- and anti-proliferative activity of testosterone [11–13]. Observational studies of the association between use of hormone replacement therapy and colorectal cancer risk in postmenopausal women have shown inverse associations with ever use of combined estrogen-progesterone therapy and with current use of estrogen therapy alone [14].

    • Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer

      2014, Nitric Oxide - Biology and Chemistry
      Citation Excerpt :

      We have observed significant effects of an H2S donor (diallyl disulfide in reducing the number of intestinal polyps in APCmin mice, (unpublished). However, there are conflicting reports in the literature on the chemopreventative potential of this donor, even when tested in the same model [51,52]. The observation that neither naproxen nor TBZ could produce the same reduction of aberrant crypt foci formation as seen with the hybrid molecule (ATB-346) is suggestive that both suppression of COX and delivery of H2S is required to achieve the observed effect.

    • The androgen receptor CAG repeat: A modifier of carcinogenesis?

      2002, Molecular and Cellular Endocrinology
    View all citing articles on Scopus
    View full text